financetom
Business
financetom
/
Business
/
Astrotech Q1 revenue rises sequentially
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Astrotech Q1 revenue rises sequentially
Nov 13, 2025 1:53 PM

Overview

* Astrotech fiscal Q1 2026 revenue up 35% from prior qtr due to higher grant revenue

* Company reports fiscal Q1 net loss of $3.47 mln, slightly higher than last year

* Astrotech ( ASTC ) deployed TRACER 1000 in 34 locations across 16 countries

Outlook

* Company expects sales acceleration in 2026 due to expanded global opportunities

* Astrotech ( ASTC ) sees growing opportunities in transportation and cargo screening markets

* Company anticipates increased customer adoption of its mass spectrometry systems

Result Drivers

* REVENUE GROWTH - Revenue increased 35% in Q1 2026 driven by more grant revenue and consumable sales from 1st Detect

* GLOBAL EXPANSION - TRACER 1000 deployed in 34 locations across 16 countries, expanding market presence

* MARKET OPPORTUNITIES - Co sees growing opportunities in transportation, cargo screening, and environmental testing

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q1 $297,000

Revenue

Q1 EPS -$2.07

Q1 Net -$3.47

Income mln

Q1 Gross $188,000

Profit

Q1 $3.72

Operatin mln

g

Expenses

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Copyright 2023-2026 - www.financetom.com All Rights Reserved